BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply

Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and ...

June 12, 2025 | News

Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases

- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...

June 12, 2025 | News

ClavystBio and A*STAR Join Forces to Accelerate MedTech Venture Creation and Commercialisation in Singapore

ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), S...

June 11, 2025 | News

HTL Biotechnology Unveils €12M Sterile Hyaluronic Acid Unit, Strengthening France’s Biomanufacturing Leadership

HTL Biotechnology confirms its position as a globalleader in the development and production of pharmaceutical-grade biopolymers, by inauguratin...

June 09, 2025 | News

QureBio Secures Nearly CNY 100 Million in Series C1 Funding Led by Efung Capital

Qure Biotechnology (Shanghai) Co., Ltd. (QureBio) announced that it has completed a Series C1 financing round. The financing raised nearly CNY 100 mil...

June 06, 2025 | News

Quadria Capital Closes Oversubscribed $1.07B Fund III to Drive Healthcare Innovation Across India and Southeast Asia

Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia heal...

May 27, 2025 | News

Pfizer Strikes $1.25B Ex-China Licensing Deal With China’s 3SBio for Cancer Antibody SSGJ-707

Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutic...

May 20, 2025 | News

GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...

May 15, 2025 | News

Novo Holdings Makes First Pharmaceutical Manufacturing Investment in India with Stake in SCHOTT Poonawalla

Novo Holdings, a global life sciences investor, announced its investment in SCHOTT Poonawalla, India's leading provider of high-quality drug containment an...

May 14, 2025 | News

Eli Lilly Commits $250M to Purdue University in Landmark U.S. Industry-Academic Alliance

Eli Lilly and Company (NYSE: LLY) and Purdue University announced a significant expansion of their long-standing alliance, with Lilly'...

May 13, 2025 | News

Beijing Tide Begins Phase II Trial of First-in-Class Non-Opioid CPSP Drug TRD205

Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class ...

May 06, 2025 | News

HistoIndex Raises S$9M to Accelerate AI-Powered Digital Pathology and Launch of FibroSIGHT™

HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) di...

May 02, 2025 | News

Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion

Amgen (NASDAQ: AMGN), a global leader in biotechnology, announced a $900 million expansion of its state-of-the-art biomanufacturing facility in New A...

April 29, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Stay Connected